Evidence map›Paper›PMID 37143811›Full record

ArticleNanoscale advances2023

Controlling simonkolleite crystallisation

Shaoqing Qu, Eftychios Hadjittofis, Francisco Malaret, Jason Hallett, Rachel Smith, Kyra Sedransk Campbell

Open access · goldAbstract read
In one paragraph

Article in Nanoscale advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Shaoqing QuThe University of Sheffield, Department of Chemical and Biological Engineering Sheffield UK k.sedransk@sheffield.ac.uk.
Eftychios HadjittofisThe University of Sheffield, Department of Chemical and Biological Engineering Sheffield UK k.sedransk@sheffield.ac.uk.
Francisco MalaretImperial College London, Department of Chemical Engineering London UK.ORCID https://orcid.org/0000-0002-5717-3629
Jason HallettImperial College London, Department of Chemical Engineering London UK.ORCID https://orcid.org/0000-0003-3431-2371
Rachel SmithThe University of Sheffield, Department of Chemical and Biological Engineering Sheffield UK k.sedransk@sheffield.ac.uk.
Kyra Sedransk CampbellThe University of Sheffield, Department of Chemical and Biological Engineering Sheffield UK k.sedransk@sheffield.ac.uk.ORCID https://orcid.org/0000-0001-5927-7221
University of Sheffield · GBImperial College London · GBUCB Pharma (Belgium) · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zinc oxide nanoparticles, with a hexagonal flake structure, are of significant interest across a range of applications including photocatalysis and biomedicine. Simonkolleite (Zn

Identifiers

PMID37143811
PMCPMC10153477
OpenAlexW4323025600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.